As Temasek, TPG, KKR fuel an acquisition spree, this eye-care chain is betting on something different
The post As Temasek, TPG, KKR fuel an acquisition spree, this eye-care chain is betting on something different appeared first on The Ken .
In October 2025, The Eye Foundation, a 40-year-old eye-care chain based in Coimbatore, raised Rs 650 crore for a 20% stake in the company from Verlinvest, a consumer-brands-and-retail VC fund. This investment decision was unusual for the sector, as most competitors opted for healthcare-focused private-equity funds such as Temasek, Blackstone, TPG, and KKR.
Verlinvest, which has backed companies like Epigamia, Wakefit, and Purplle, valued the company at a similar level to its competitors and offered a more favorable valuation than the latest fundraise led by Dr Agarwal. In FY27, The Eye Foundation anticipates a nearly 90% year-on-year revenue growth, reaching Rs 550 crore. The company's Ebitda margin has consistently remained above 30%, a rare achievement in the healthcare sector.
Written by urgent.news from The Ken's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
